Investigation of a transgenic mouse model of familial dilated cardiomyopathy

Journal of Molecular and Cellular Cardiology

Volumn 49, Issue 3, 2010, Pages 380-389

  Song, Weihua ^a   Dyer, Emma ^b   Stuckey, Daniel ^c   Leung, Man Ching ^a   Memo, Massimiliano ^a   Mansfield, Catherine ^a   Ferenczi, Michael ^a   Liu, Ke ^a   Redwood, Charles ^d   Nowak, Kristen ^e   Harding, Sian ^a   Clarke, Kieran ^c   Wells, Dominic ^a   Marston, Steven ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CALCIUM ION; TROPONIN I;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FAMILIAL DISEASE; GENE EXPRESSION; GENE MUTATION; HEART EJECTION FRACTION; HEART OUTPUT; HEART RATE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; SENSITIVITY ANALYSIS; TRANSGENIC MOUSE;

MUS; MUS MUSCULUS;

EID: 77955308896     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.05.009     Document Type: Article

References (48)

1. Olson T.M., Michels V.V., Thibodeau S.N., Tai Y.S., Keating M.T. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 1998, 280:750-752.
2. Mogensen J., Murphy R.T., Shaw T., Bahl A., Redwood C., Watkins H., et al. Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2004, 44:2033-2040.
3. Kamisago M., Sharma S.D., DePalma S.R., Solomon S., Sharma P., Smoot L., et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 2000, 343:1688-1696.
4. Chang A.N., Potter J.D. Sarcomeric protein mutations in dilated cardiomyopathy. Heart Fail Rev 2005, 10:225-235.
5. Robinson P., Mirza M., Knott A., Abdulrazzak H., Willott R., Marston S., et al. Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy. J Biol Chem 2002, 277:40710-40716.
6. Mirza M., Marston S., Willott R., Ashley C., Mogensen J., McKenna W., et al. Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype. J Biol Chem 2005, 280:28498-28506.
7. Mirza M., Robinson P., Kremneva E., Copeland O., Nikolaeva O., Watkins H., et al. The effect of mutations in alpha tropomyosin (E40K and E54K), that cause familial dilated cardiomyopathy, on the regulatory mechanism of cardiac muscle thin filaments. J Biol Chem 2007, 282:13487-13497.
8. Robinson P., Griffiths P.J., Watkins H., Redwood C.S. Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments. Circ Res 2007, 101:1266-1273.
9. Carballo S., Robinson P., Otway R., Fatkin D., Jongbloed J.D., de Jonge N., et al. Identification and functional characterization of cardiac troponin I as a novel disease gene in autosomal dominant dilated cardiomyopathy. Circ Res 2009, 105:375-382.
10. Venkatraman G., Harada K., Gomes A.V., Kerrick G.W., Potter J.D. Different functional properties of Troponin T mutants that cause dilated cardiomyopathy. J Biol Chem 2003, 278:41670-41676.
11. Chang A.N., Harada K., Ackerman M.J., Potter J.D. Functional consequences of hypertrophic and dilated cardiomyopathy-causing mutations in alpha-tropomyosin. J Biol Chem 2005, 280:34343-34349.
12. Morimoto S., Lu Qw., Harada K., Takahashi-Yanaga F., Minakami R., Ohta M., et al. Ca2+-desensitizing effect of a deletion mutation Delta K210 in cardiac troponin T that causes familial dilated cardiomyopathy. Proc Natl Acad Sci 2002, 99:913-918.
13. Lu Q.W., Morimoto S., Harada K., Du C.K., Takahashi-Yanaga F., Miwa Y., et al. Cardiac troponin T mutation R141W found in dilated cardiomyopathy stabilizes the troponin T-tropomyosin interaction and causes a Ca(2+) desensitization. J Mol Cell Cardiol 2003, 35:1421-1427.
14. Olson T.M., Kishimoto N.Y., Whitby F.G., Michels V.V. Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy. J Mol Cell Cardiol 2001, 33:723-732.
15. Suurmeijer A.J., Clement S., Francesconi A., Bocchi L., Angelini A., Van Veldhuisen D.J., et al. Alpha-actin isoform distribution in normal and failing human heart: a morphological, morphometric, and biochemical study. J Pathol 2003, 199:387-397.
16. Copeland O., Nowak K.J., Laing N.G., Ravenscroft G., Marston S. Quantitative assay of skeletal α-actin expression in normal and pathological human and mouse hearts. Biophys J 2009, 96:499a.
17. Kumar A., Crawford K., Flick R., Klevitsky R., Lorenz J.N., Bove K.E., et al. Transgenic overexpression of cardiac actin in the mouse heart suggests coregulation of cardiac, skeletal and vascular actin expression. Transgenic Res 2004, 13:531-540.
18. Cook S., Clerk A., Sugden P. Are transgenic mice the 'Älkahest' to understanding myocardial hypertrophy and failure?. J Mol Cell Cardiol 2008, 46:118-129.
19. Molkentin J.D., Robbins J. With great power comes great responsibility: using mouse genetics to study cardiac hypertrophy and failure. J Mol Cell Cardiol 2008, 46:130-136.
20. Du C.K., Morimoto S., Nishii K., Minakami R., Ohta M., Tadano N., et al. Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation. Circ Res 2007, 101:185-194.
21. Redwood C., Lohmann K., Bing W., Esoposito G., Elliott K., Abdulrazzak H., et al. Investigation of a truncated troponin T that causes familial hypertrophic cardiomyopathy: Ca2+ regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild-type peptide. Circ Res 2000, 86:1146-1152.
22. Rajan S., Ahmed R.P., Jagatheesan G., Petrashevskaya N., Boivin G.P., Urboniene D., et al. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity. Circ Res 2007, 101:205-214.
23. Davies J.K., Wells D.J., Liu K., Whitrow H.R., Daniel T.D., Grignani R., et al. Characterization of the role of gamma2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome. Am J Physiol Heart Circ Physiol 2006, 290:H1942-H1951.
24. Stuckey D., Carr C., Tyler D.J., Aasum E., Clarke K. Novel MRI method to detect altered left ventricular ejection and filling patterns in rodent models of disease. Magn Reson Med 2008, 60:582-587.
25. Nishio R., Sasayama S., Matsumori A. Left ventricular pressure-volume relationship in a murine model of congestive heart failure due to acute viral myocarditis. J Am Coll Cardiol 2002, 40:1506-1514.
26. Davies C.H., Davia K., Bennett J.G., Pepper J.R., Poole-Wilson P.A., Harding S.E. Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. Circulation 1995, 92:2540-2549.
27. Palmer B.M., Fishbaugher D.E., Schmitt J.P., Wang Y., Alpert N.R., Seidman C.E., et al. Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardium. Am J Physiol Heart Circ Physiol 2004, 287:H91-H99.
28. Messer A., Gallon C., McKenna W., Elliott P., Dos Remedios C., Marston S. The use of phosphate-affinity SDS-PAGE to measure the troponin I phosphorylation site distribution in human heart muscle. Proteomics Clin Appl 2009, 3:1371-1382.
29. Messer A.E., Jacques A.M., Marston S.B. Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure. J Mol Cell Cardiol 2007, 42:247-259.
30. Dyer E., Jacques A., Hoskins A., Ward D., Gallon C., Messer A., et al. Functional analysis of a unique troponin c mutation, Gly159Asp that causes familial dilated cardiomyopathy, studied in explanted heart muscle. Circulation: Heart Failure 2009, 2:456-464.
31. Jacoby C., Molojavyi A., Flögel U., Merx M.W., Ding Z., Schrader J. Direct comparison of magnetic resonance imaging and conductance microcatheter in the evaluation of left ventricular function in mice. Basic Res Cardiol 2006, 101:87-95.
32. Vandekerckhove J., Bugaisky G., Buckingham M. Simultaneous expression of skeletal muscle and heart actin proteins in various striated muscle tissues and cells. A quantitative determination of the two actin isoforms. J Biol Chem 1986, 261:1838-1843.
33. Alonso S., Garner I., Vandekerckhove J., Buckingham M. Genetic analysis of the interaction between cardiac and skeletal actin gene expression in striated muscle of the mouse. J Mol Biol 1990, 211:727-738.
34. Nier V., Schultz I., Brenner B., Forssmann W., Raida M. Variability in the ratio of mutant to wildtype myosin heavy chain present in the soleus muscle of patients with familial hypertrophic cardiomyopathy. A new approach for the quantification of mutant to wildtype protein. FEBS Lett 1999, 461:246-252.
35. Bottinelli R., Coviello D.A., Redwood C.S., Pellegrino M.A., Maron B.J., Spirito P., et al. A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity. Circ Res 1998, 82:106-115.
36. Clarke N.F., Ilkovski B., Cooper S., Valova V.A., Robinson P.J., Nonaka I., et al. The pathogenesis of ACTA1-related congenital fiber type disproportion. Ann Neurol 2007, 61:552-561.
37. D'Amico A., Graziano C., Pacileo G., Petrini S., Nowak K.J., Boldrini R., et al. Fatal hypertrophic cardiomyopathy and nemaline myopathy associated with ACTA1 K336E mutation. Neuromuscul Disord 2006, 16:548-552.
38. Elliott K., Watkins H., Redwood C.S. Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy. J Biol Chem 2000, 275:22069-22074.
39. Tobacman L., Sawyer D. Calcium binds cooperatively to the regulatory sites of the cardiac thin filament. J Biol Chem 1990, 265:931-939.
40. Wong W.W., Doyle T.C., Cheung P., Olson T.M., Reisler E. Functional studies of yeast actin mutants corresponding to human cardiomyopathy mutations. J Musc Res Cell Motil. 2002, 22:665-674.
41. van der Velden J., Papp Z., Zaremba R., Boontje N.M., de Jong J.W., Owen V.J., et al. Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins. Cardiovasc Res 2003, 57:37-47.
42. Hamdani N., de Waard M., Messer A.E., Boontje N.M., Kooij V., van Dijk S., et al. Myofilament dysfunction in cardiac disease from mice to men. J Musc Res Cell Motil. 2009, 29:189-201.
43. Houser S.R., Margulies K.B. Is depressed myocyte contractility centrally involved in heart failure?. Circ Res 2003, 92:350-358.
44. A. Messer. Structural and functional polymorphisms of troponin in failing heart. PhD Thesis. London: London; 2007.
45. Jacques A., Copeland O., Messer A., Gallon C., King C., McKenna W., et al. Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscle. J Mol Cell Cardiol 2008, 45:209-216.
46. Hamdani N., Kooij V., van Dijk S., Merkus D., Paulus W.J., Remedios C.D., et al. Sarcomeric dysfunction in heart failure. Cardiovasc Res 2008, 77:649-658.
47. Geisterfer-Lowrance A.A., Christe M., Conner D.A., Ingwall J.S., Schoen F.J., Seidman C.E., et al. A mouse model of familial hypertrophic cardiomyopathy. Science 1996, 272:731-734.
48. Schuermann F., Schlossarek S., Mearini G., Geetz B., Eschenhagen T., Carrier L. Adrenergic stress unmasks exaggerated septal hypertrophy and proteasome impairment in heterozygous cMyBP-C mutant mice. Circulation 2008, 118(Suppl 2):S521.